Recent data has shown that
hepatitis surface antigen clearance is associated with reduced disease progression to liver cirrhosis and liver cancer.
HBsAg was detected using
Hepatitis Surface Antigen Rapid Test (Diagnostar, UK) as recommended by manufacturer.
* Anti-HBs--antibody to
hepatitis surface antigen confers immunity (either through the vaccine or through exposure).
This first dose in the 3-dose series should be monovalent HepB and should be delayed only if a physician so orders and if the mother is documented to be
hepatitis surface antigen negative.